iBio Receives Patent Allowance in China for Fusion Protein Compositions and Technology

April 24, 2014 iBio, Inc., a leader in plant-based biotechnology for developing and manufacturing biological products, reported the allowance of a Chinese patent on its lichenase fusion protein technology for therapeutic proteins and vaccines. “The invention covered by this patent enables increased efficiency in the expression of a range of commercially important proteins,” said Dr. Wayne Fitzmaurice, iBio’s vice-president of …